Publication | Closed Access

Treatment of Poorly Differentiated Glioma Using a Combination of Monoclonal Antibodies to Extracellular Connexin-43 Fragment, Temozolomide, and Radiotherapy

Neuro-oncologyTumoral PathologyTumor InnervationMedicinePathologyConnexin-43 FragmentMonoclonal AntibodiesHigh-grade GliomasPoorly Differentiated GliomaCancer TreatmentRadiation OncologyOncologyGlioma